Core One Labs Acquires Awakened Biosciences
February 11, 2022
Core One Labs Inc. (CSE: COOL) has completed the acquisition of all outstanding share capital of Awakened Biosciences Inc., adding Awakened's provisional patents and novel synthetic psilocybin production technologies to Core One's portfolio. The deal expands Core One's R&D and manufacturing capabilities in psychedelic therapeutics and secures IP that could enable lower-cost, scalable production and potential near-term revenue from non-controlled psilocybin-based compounds.
- Buyers
- Core One Labs Inc.
- Targets
- Awakened Biosciences Inc.
- Sellers
- Shareholders of Awakened Biosciences Inc.
- Industry
- Biotechnology
- Location
- Ontario, Canada
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.